4.6 Article

Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies, and the Evaluation of Their ADMET Properties

期刊

MOLECULES
卷 26, 期 21, 页码 -

出版社

MDPI
DOI: 10.3390/molecules26216331

关键词

antioxidants; enzyme inhibition; in vitro assays; triterpenes; virtual screening; inflammation; Alzheimer's disease

资金

  1. King Saud University Researchers Supporting Project [RSP-2021/294]
  2. King Saud University, Riyadh, Saudi Arabia

向作者/读者索取更多资源

The antioxidant and enzyme inhibitory potential of fifteen cycloartane-type triterpenes were investigated, revealing high activities in certain compounds that indicate potential pharmacological value.
The antioxidant and enzyme inhibitory potential of fifteen cycloartane-type triterpenes' potentials were investigated using different assays. In the phosphomolybdenum method, cycloalpioside D (6) (4.05 mmol TEs/g) showed the highest activity. In 1,1-diphenyl-2-picrylhydrazyl (DPPH*) radical and 2,2 '-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) cation radical scavenging assays, cycloorbicoside A-7-monoacetate (2) (5.03 mg TE/g) and cycloorbicoside B (10) (10.60 mg TE/g) displayed the highest activities, respectively. Oleanolic acid (14) (51.45 mg TE/g) and 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol 7-monoacetate (4) (13.25 mg TE/g) revealed the highest reducing power in cupric ion-reducing activity (CUPRAC) and ferric-reducing antioxidant power (FRAP) assays, respectively. In metal-chelating activity on ferrous ions, compound 2 displayed the highest activity estimated by 41.00 mg EDTAE/g (EDTA equivalents/g). The tested triterpenes showed promising AChE and BChE inhibitory potential with 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol 2 ',3 ',4 ',7-tetraacetate (3), exhibiting the highest inhibitory activity as estimated from 5.64 and 5.19 mg GALAE/g (galantamine equivalent/g), respectively. Compound 2 displayed the most potent tyrosinase inhibitory activity (113.24 mg KAE/g (mg kojic acid equivalent/g)). Regarding alpha-amylase and alpha-glucosidase inhibition, 3-O-beta-d-xylopyranoside-(23R,24S)-16 beta,23;16 alpha,24-diepoxycycloart-25(26)-en-3 beta,7 beta-diol (5) (0.55 mmol ACAE/g) and compound 3 (25.18 mmol ACAE/g) exerted the highest activities, respectively. In silico studies focused on compounds 2, 6, and 7 as inhibitors of tyrosinase revealed that compound 2 displayed a good ranking score (-7.069 kcal/mole) and also that the & UDelta;G free-binding energy was the highest among the three selected compounds. From the ADMET/TOPKAT prediction, it can be concluded that compounds 4 and 5 displayed the best pharmacokinetic and pharmacodynamic behavior, with considerable activity in most of the examined assays.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据